Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback